Vancouver’s RepliCel to Receive C$5.09M Upfront from Chinese Partner

Vancouver, B.C.-headquartered RepliCel Life Sciences Inc. has a new binding term sheet with YOFOTO (China) Health Industry Co. Ltd., moving the two parties closer to finalizing a strategic partnership in Greater China (Mainland China, Hong Kong, Macau, and Taiwan) first announced in January 2018. The revised term sheet involves an upfront investment of C$5.09-million and includes milestone payments of up to C$4.75 million, sales royalties, and a commitment by YOFOTO to spend a minimum of C$7 million on the RepliCel programs over the next five years in Greater China. RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting the skin and tendons.

Use 'AND' or 'OR' to refine your search.

Use quotes " " to get exact matches or remove them to get more results.